comparemela.com
Home
Live Updates
Stephane Degove - Breaking News
Pages:
Latest Breaking News On - Stephane degove - Page 2 : comparemela.com
Atamyo Therapeutics Submits CTA in Europe for ATA-100, Its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9
Company also appoints Sophie Olivier, M.D., Chief Medical Officer, joining co-founders Stephane Degove, Chief Executive Officer, and Isabelle Richard, Ph.D., Chief Scientific Officer Atamyo is a
City of
United kingdom
Kostenloser wertpapierhandel
Stephane degove
Charles craig
Sophie olivier
Isabelle richard
Pediatric team
Progressive muscular dystrophies laboratory at genethon
European medicines agency
Women health
Opus biotech communications
Chief medical officer
Chief executive officer
Chief scientific
Clinical trial application
vimarsana © 2020. All Rights Reserved.